Herpes Simplex Virus Type 1 Entry Is Inhibited by the Cobalt Chelate Complex CTC-96

The CTC series of cobalt chelates display in vitro and in vivo activity against herpes simplex virus types 1 and 2 (HSV-1 and HSV-2). The experiments described here identify the stage in the virus life cycle where CTC-96 acts and demonstrate that the drug inhibits infection of susceptible cells. CTC...

Description complète

Détails bibliographiques

Publié dans:	J Virol
Auteurs principaux:	Schwartz, Jennifer A., Lium, Erik K., Silverstein, Saul J.
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2001
Sujets:	Vaccines and Antiviral Agents
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC114157/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11287561/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.9.4117-4128.2001
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!